QuantumSi Inc (QSI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, QuantumSi Inc (QSI) has a cash flow conversion efficiency ratio of -0.128x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-25.64 Million) by net assets ($200.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See QSI equity to assets ratio to measure how much of total assets are equity-financed.
QuantumSi Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how QuantumSi Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore QuantumSi Inc (QSI) investment intensity to see how much of total assets are deployed in long-term investments.
QuantumSi Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of QuantumSi Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S&P Syndicate Public Company Limited
BK:SNP
|
0.106x |
|
Faze Three Limited
NSE:FAZE3Q
|
0.025x |
|
Espey Mfg & Electronics Corp
NYSE MKT:ESP
|
0.112x |
|
Avita Medical Inc
AU:AVH
|
0.411x |
|
K2 Capital Acquisition Corporation
NASDAQ:KTWO
|
-0.003x |
|
GRIGEO AB EO -29
F:WM8
|
0.033x |
|
All For One Steeb AG
F:A1OS
|
-0.010x |
|
Gs Global
KO:001250
|
0.022x |
Annual Cash Flow Conversion Efficiency for QuantumSi Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of QuantumSi Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of QuantumSi Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $220.23 Million | $-94.72 Million | -0.430x | -5.53% |
| 2024-12-31 | $215.42 Million | $-87.80 Million | -0.408x | -17.72% |
| 2023-12-31 | $271.62 Million | $-94.04 Million | -0.346x | -37.13% |
| 2022-12-31 | $358.71 Million | $-90.56 Million | -0.252x | -80.25% |
| 2021-12-31 | $477.03 Million | $-66.81 Million | -0.140x | +84.48% |
| 2020-12-31 | $36.09 Million | $-32.57 Million | -0.903x | -4.30% |
| 2019-12-31 | $35.48 Million | $-30.71 Million | -0.865x | -- |
About QuantumSi Inc
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for … Read more